细胞色素C P450 17A1抗体
20 lyase; CP17A_HUMAN; CPT7; CYP17; CYP17A1; CYPXVII; Cytochrome P450 17A1; Cytochrome P450 family 17; Cytochrome P450 family 17 subfamily A polypeptide 1; Cytochrome p450 XVIIA1; Cytochrome p450, sub
腺苷酸环化酶1抗体
3'5' cyclic AMP synthetase; ADCY1; adenyl cyclase; Adenylate cyclase 1; adenylate cyclase type I; ATP pyrophosphate lyase; Brain adenylate cyclase 1; Ca(2+)/calmodulin activated adenylyl cyclase; EC 4
P53诱导细胞凋亡抑制蛋白抗体
Inhibitor of p53 induced apoptosis beta; IPIA beta; NDK-H 5; NDP kinase homolog 5; NM23 H5; Nm23-M5; NM23H5; Non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase); Nonmetastatic
肌萎缩侧索硬化症相关蛋白FGGY抗体
fggy; FGGY carbohydrate kinase domain containing; FGGY carbohydrate kinase domain-containing protein; FGGY_HUMAN; FLJ10986; MGC94804; OTTHUMP00000010078; OTTHUMP00000010081; OTTHUMP00000010082; OTTHUM
囊性组织液体蛋白15抗体
GCDGP15; GCDGP 15; GCDGP-15; Gp17; GPIP4; Gross cystic disease fluid protein 15; Prolactin induced protein; Prolactin inducible protein precursor; SABP; Secretory actin binding protein.PIP_HUMAN
Anti-CRMP2 Polyclonal Antibody
Anti-CRMP2 Polyclonal Antibody 应用 WB IHC 稀释比例 WB 1:500-2000. IHC 1:25-100. 交叉反应 Human Mouse Rat